SMSPHARMA

💊 Business Strength

📊 Recent Price Action Stock recently showed: Sharp single-day rallies (~5–7%) Outperformance vs broader pharma sector in short bursts 👉 Suggests trader interest + momentum-driven moves 💊 Business Strength Core business: Active Pharmaceutical Ingredients (API) Supplies to: Global pharma companies Strong presence in: Anti-ulcer Anti-viral Anti-diabetic segments 🇺🇸 Regulatory & Compliance Earlier: Successful USFDA inspection with no major observations Positive for: Export growth Global credibility ⚖️ Tax Notice (Recent Negative Trigger) Received income tax demand (~₹7 crore) Company stated: No major financial impact expected Reviewing legal options 📅 Upcoming Trigger Q4 & FY26 results expected Trading window closed ahead of results Market waiting for: Continuation of strong growth Margin stability ⚠️ Key Concerns Stock already ran up sharply → risk of consolidation Earnings growth good, but not “high-growth pharma” level Margin volatility possible due to: Raw material costs